GERMANTOWN, Md., May 21 /PRNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve continuous glucose monitoring for people with diabetes, today announced the completion of a $10 million financing with a strategic investor. This new investor purchased shares of the Company's existing Series C preferred stock. No product development or intellectual property rights were transferred as a result of this investment. Previous venture investors in Sensors for Medicine and Science, Inc., include New Enterprise Associates, HealthCare Ventures, Rho Management, Anthem Capital and Abingworth Bioventures.
For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.
CONTACT: Carroll Cummings of Sensors for Medicine and Science, Inc.,
+1-301-515-7260, mscc@s4ms.com
Web site: http://www.s4ms.com/
